Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPTIMUS-PRIME: HES 130/0.4 vs Saline for CPB Priming
NCT02906514Phase 3Completed
- Sponsor
- Hospices Civils de Lyon
- Start
- Dec 2016
- Primary completion
- Aug 2017
- Modality
- Polymer-based Nanoparticles, Lipid-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of hetastarch in cardiac surgery, sponsored by Hospices Civils de Lyon. Started Dec 2016; status: completed.
02
Drugs
hetastarch
03
Conditions
cardiac surgery
Beyond the preview
Go deeper on NCT02906514.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02906514.